These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 14151899)
1. SOME EFFECTS OF MODIFICATIONS OF THE AMINOSTYRYL PORTION OF 4-(4-DIMETHYLAMINOSTYRYL)QUINOLINE. BAHNER CT Acta Unio Int Contra Cancrum; 1964; 20():253-5. PubMed ID: 14151899 [No Abstract] [Full Text] [Related]
6. A LABORATORY EVALUATION OF 1,4-DIMETHYL-1,4-DIPHENYL-2-TETRAZENE (CENTRAZENE), A CARCINOSTATIC COMPOUND. SLOBODA AE; VOGEL AW Cancer Res; 1964 Apr; 24():461-9. PubMed ID: 14147819 [No Abstract] [Full Text] [Related]
7. ANTITUMOROUS SUBSTANCES WITH RADIOMIMETIC AND RADIOPROTECTIVE GROUPS. HILLER SA; LIDAKS MJ; ZIDERMANE AA; GERMANE SK; GRIGALINOVICH GA; DAUVARTS AZ; KRAVCHENKO IM; PRESS BO Acta Unio Int Contra Cancrum; 1964; 20():147-50. PubMed ID: 14151871 [No Abstract] [Full Text] [Related]
8. EXPERIMENTAL RESULTS OF NEW ANTICANCER DRUG-PHENESTERIN. DEGTEVA SA Acta Unio Int Contra Cancrum; 1964; 20():153-6. PubMed ID: 14151873 [No Abstract] [Full Text] [Related]
9. EXPERIMENTAL USE OF ANTICANCER COMPOUNDS IN THE CONTROL OF INTRAPERITONEAL MALIGNANT DISEASE. MCKIBBIN B; GAZET J; HOPPE E Surg Forum; 1963; 14():131-3. PubMed ID: 14064482 [No Abstract] [Full Text] [Related]
10. [RESEARCH ON THE ACTIVITY OF DAUNOMYCIN ON NORMAL AND NEOPLASTIC CELLS CULTIVATED IN VITRO]. DIMARCO A; SOLDATI M; FIORETTI A; DASDIA T Tumori; 1963; 49():235-51. PubMed ID: 14080364 [No Abstract] [Full Text] [Related]
11. PRECLINICAL STUDIES FOR THE CHARACTERISATION OF NEW ANTICANCER AGENTS IN ANIMAL EXPERIMENTS. BROCK N Acta Unio Int Contra Cancrum; 1964; 20():45-7. PubMed ID: 14151959 [No Abstract] [Full Text] [Related]
12. THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213). BOLLAG W Cancer Chemother Rep; 1963 Dec; 33():1-4. PubMed ID: 14102078 [No Abstract] [Full Text] [Related]
13. DAUNOMYCIN: A NEW ANTIBIOTIC WITH ANTITUMOR ACTIVITY. DIMARCO A; GAETANI M; DORIGOTTI L; SOLDATI M; BELLINI O Cancer Chemother Rep; 1964 May; 38():31-8. PubMed ID: 14167466 [No Abstract] [Full Text] [Related]
15. BIOCHEMICAL PERSPECTIVES IN CANCER RESEARCH. POTTER VR Cancer Res; 1964 Aug; 24():1085-98. PubMed ID: 14209402 [No Abstract] [Full Text] [Related]
16. ANTITUMOR ACTIVITY OF GOSSYPOL IN EXPERIMENTS ON TRANSPLANTABLE TUMORS. VERMEL EM; KRUGLYAK SA Fed Proc Transl Suppl; 1965; 24():106-8. PubMed ID: 14275562 [No Abstract] [Full Text] [Related]
17. THE USE OF ANTICANCER AGENTS FOR CONTROL OF TUMOR GROWTH IN THE PERITONEAL CAVITY AFTER SEEDING WITH AN EXPERIMENTAL TUMOR. VERNICK JJ; OATES GD; MAGELL J; FRIED C J Surg Res; 1964 Dec; 4():559-61. PubMed ID: 14241848 [No Abstract] [Full Text] [Related]
18. I. RATIONAL APPROACHES TO THE DEVELOPMENT OF ANTICANCER DRUGS. POSSIBLE IMPROVEMENTS OF CYTOTOXIC AGENTS. ROSS WC Acta Unio Int Contra Cancrum; 1964; 20():33-6. PubMed ID: 14151924 [No Abstract] [Full Text] [Related]
19. UNCOUPLING THE OXIDATIVE PHOSPHORYLATION IN THE COMBINED CHEMOTHERAPY OF CANCER. BACIGALUPO G Acta Unio Int Contra Cancrum; 1964; 20():52-3. PubMed ID: 14151980 [No Abstract] [Full Text] [Related]